![The EU CHMP recommends approval of Pfizer's 2 JAK inhibitors Cibinqo (abxitinib) and Xeljanz (tofacitinib)! - Knowledge - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd The EU CHMP recommends approval of Pfizer's 2 JAK inhibitors Cibinqo (abxitinib) and Xeljanz (tofacitinib)! - Knowledge - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd](https://www.hsppharma.com/Content/uploads/2021524038/202111041625269740dbb43015449f9b870c64b8281029.png)
The EU CHMP recommends approval of Pfizer's 2 JAK inhibitors Cibinqo (abxitinib) and Xeljanz (tofacitinib)! - Knowledge - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd
![Pfizer Xeljanz, Tofacitinib (tofacitinib citrate), JAK inhibitor, 11mg tablets, once daily treatment in sustained release tablet form, France Stock Photo - Alamy Pfizer Xeljanz, Tofacitinib (tofacitinib citrate), JAK inhibitor, 11mg tablets, once daily treatment in sustained release tablet form, France Stock Photo - Alamy](https://c8.alamy.com/comp/2FMCWHR/pfizer-xeljanz-tofacitinib-tofacitinib-citrate-jak-inhibitor-11mg-tablets-once-daily-treatment-in-sustained-release-tablet-form-france-2FMCWHR.jpg)
Pfizer Xeljanz, Tofacitinib (tofacitinib citrate), JAK inhibitor, 11mg tablets, once daily treatment in sustained release tablet form, France Stock Photo - Alamy
![Pfizer Announces FDA Approval of XELJANZ® XR (tofacitinib citrate) Extended-Release Tablets, the First and Only Once-Daily Oral JAK Inhibitor Treatment for Rheumatoid Arthritis | Business Wire Pfizer Announces FDA Approval of XELJANZ® XR (tofacitinib citrate) Extended-Release Tablets, the First and Only Once-Daily Oral JAK Inhibitor Treatment for Rheumatoid Arthritis | Business Wire](https://mms.businesswire.com/media/20160224006053/en/511097/5/2486042_XELJANZ_XR_LOGO_cmyk_lock_up+%281%29.jpg)
Pfizer Announces FDA Approval of XELJANZ® XR (tofacitinib citrate) Extended-Release Tablets, the First and Only Once-Daily Oral JAK Inhibitor Treatment for Rheumatoid Arthritis | Business Wire
![Xeljanz XR (tofacitinib citrate) Modified Release Tablets For the Treatment of Rheumatoid Arthritis - Clinical Trials Arena Xeljanz XR (tofacitinib citrate) Modified Release Tablets For the Treatment of Rheumatoid Arthritis - Clinical Trials Arena](https://www.drugdevelopment-technology.com/wp-content/uploads/static-progressive/nri/Drug%20development/Projects/Xeljanz/xeljanz.jpg)
Xeljanz XR (tofacitinib citrate) Modified Release Tablets For the Treatment of Rheumatoid Arthritis - Clinical Trials Arena
![FDA Crisis for Pfizer: The Impact of an FDA Warning On the Company – Cases and Tools in Biotechnology Management FDA Crisis for Pfizer: The Impact of an FDA Warning On the Company – Cases and Tools in Biotechnology Management](https://ecampusontario.pressbooks.pub/app/uploads/sites/73/2019/04/JAK-pathway.jpg)
FDA Crisis for Pfizer: The Impact of an FDA Warning On the Company – Cases and Tools in Biotechnology Management
![JAK Inhibitors Are Coming and They Are the Biggest Eczema Development in Years | National Eczema Association JAK Inhibitors Are Coming and They Are the Biggest Eczema Development in Years | National Eczema Association](https://nationaleczema.org/wp-content/uploads/2021/01/JAK-Image-copy.png)
JAK Inhibitors Are Coming and They Are the Biggest Eczema Development in Years | National Eczema Association
![Molecular structures of FDA approved and investigational JAK inhibitors. | Download Scientific Diagram Molecular structures of FDA approved and investigational JAK inhibitors. | Download Scientific Diagram](https://www.researchgate.net/publication/343178324/figure/fig3/AS:916637297426433@1595554770745/Molecular-structures-of-FDA-approved-and-investigational-JAK-inhibitors.jpg)
Molecular structures of FDA approved and investigational JAK inhibitors. | Download Scientific Diagram
![Molecules | Free Full-Text | Inside Perspective of the Synthetic and Computational Toolbox of JAK Inhibitors: Recent Updates Molecules | Free Full-Text | Inside Perspective of the Synthetic and Computational Toolbox of JAK Inhibitors: Recent Updates](https://www.mdpi.com/molecules/molecules-25-03321/article_deploy/html/images/molecules-25-03321-g001.png)
Molecules | Free Full-Text | Inside Perspective of the Synthetic and Computational Toolbox of JAK Inhibitors: Recent Updates
![FDA approves JAK inhibitors as 2nd-line systemic therapy in atopic dermatitis < Pharma < Article - KBR FDA approves JAK inhibitors as 2nd-line systemic therapy in atopic dermatitis < Pharma < Article - KBR](https://cdn.koreabiomed.com/news/photo/202201/12995_13449_5519.jpg)